NAD Says Release Of Supplement Cases Close; FDA Discusses Claims
This article was originally published in The Tan Sheet
Executive Summary
The first two dietary supplement cases reviewed by the National Advertising Division through a Council for Responsible Nutrition initiative are "imminently closing," according to a NAD attorney
You may also be interested in...
CRN Grants $500K To NAD For Increased Dietary Supplement Monitoring
CRN is committing nearly half a million dollars over a three year period to triple the annual number of dietary supplement cases reviewed by the Council of Better Business Bureaus' National Advertising Division (NAD)
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers